Institut de recherche en immunologie et en cancérologie (IRIC)
- Jean-François Leprince
JL
Jean-François Leprince
Director at Institut de recherche en immunologie et en cancérologie (IRIC)
Trained as a chemical engineer, Jean-François LePrince is currently a Managing Partner at CTI Life Sciences Fund. His career path began at Dow Chemical Company, where he held various senior management positions before becoming President of Hoechst Marion Roussel Canada, then of Aventis Canada. Serving on several Boards, Jean-François LePrince is Chairman of the Board of IRICoR.
Org chart
Timeline
Director
Current role